Avalon Pharmaceuticals, Inc. (NASDAQ: AVRX), a biopharmaceutical company, is committed to discovering, developing and commercializing superior cancer therapeutics. The company’s proprietary platform, AvalonRx®, is designed to discover and develop therapeutics for pathways that have been characterized as “undruggable” in the past. For further information, visit the Company’s web site at www.avalonrx.com.
Avalon Pharmaceuticals, Inc. (NASDAQ: AVRX)
November 3, 2008 at 4:30am
Archives
Select A Month